87 results
424B3
PRTG
Portage Biotech Inc
28 Feb 24
Prospectus supplement
5:19pm
of operations, the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. Accordingly
6-K
EX-99.2
PRTG
Portage Biotech Inc
28 Feb 24
Current report (foreign)
5:17pm
will continue as a going concern and that contemplates the continuity of operations, the realization of assets and the satisfaction of liabilities
S-8
EX-4.2
PRTG
Portage Biotech Inc
1 Dec 23
Registration of securities for employees
4:05pm
, is earned or paid out upon the satisfaction of one or more performance goals will not be considered assumed if the Company or its successor modifies any
424B3
PRTG
Portage Biotech Inc
28 Nov 23
Prospectus supplement
4:03pm
will continue as a going concern and that contemplates the continuity of operations, the realization of assets and the satisfaction of liabilities
6-K
EX-99.2
PRTG
Portage Biotech Inc
28 Nov 23
Current report (foreign)
4:01pm
of operations, the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. Accordingly, the accompanying
F-1
EX-5.1
0ylhdysvc
31 Oct 23
Registration statement (foreign)
4:05pm
6-K
EX-10.1
7hq5z
3 Oct 23
Current report (foreign)
4:05pm
6-K
EX-5.1
ciza8kxoeu4jqu ty
3 Oct 23
Current report (foreign)
4:05pm
6-K
EX-4.1
39ounue ldshz
3 Oct 23
Current report (foreign)
4:05pm
6-K
EX-4.2
71bqgfkkwnlw jcxo0
3 Oct 23
Current report (foreign)
4:05pm
6-K
EX-4.4
t4xq 30zz832ue
3 Oct 23
Current report (foreign)
4:05pm
6-K
EX-4.5
md5a9shbxwvuk
3 Oct 23
Current report (foreign)
4:05pm
6-K
EX-4.3
9g5zghg h04i
3 Oct 23
Current report (foreign)
4:05pm
424B5
hkxdhzry5 33gxz2m
2 Oct 23
Prospectus supplement for primary offering
6:01pm
6-K
EX-99.1
p3a8oteelmo903e2ff
29 Sep 23
Portage Biotech Announces $6.0 Million Registered Direct Offering
8:01am
6-K
EX-99.2
xmvpsp 6ll1tz
29 Aug 23
Current report (foreign)
4:01pm